CD Biosynsis offers state-of-the-art Chlamydomonas reinhardtii Base Editing Services, providing a high-precision, DNA-double-strand-break-free (DSB-free) method for single-nucleotide substitutions. While traditional CRISPR-Cas9 is powerful for creating knockouts, it often results in random indels. Base Editing (BE) allows for the direct chemical conversion of one base pair to another (e.g., C:G to T:A or A:T to G:C) at a specific genomic location. This technology is uniquely suited for Chlamydomonas research, enabling the precise engineering of photosynthetic protein domains, the introduction of herbicide resistance mutations, and the fine-tuning of metabolic enzymes without the toxicity associated with chromosomal breaks in algal cells.
Get a QuoteBase Editing in Chlamydomonas reinhardtii overcomes the low efficiency of Homology-Directed Repair (HDR) typically required for point mutations. By fusing a catalytically impaired Cas9 (nCas9) to a deaminase enzyme, we can target a specific window in the algal genome and convert DNA bases with high accuracy. This approach is vital for functional proteomics—allowing researchers to change a single amino acid in a light-harvesting complex or an ATP synthase subunit to observe immediate functional consequences. Our services utilize algal-codon-optimized base editors to ensure high expression and efficiency despite the host's 64% GC-bias and silencing mechanisms.
Target Mechanism
Utilizes a cytidine deaminase (e.g., APOBEC) to convert Cytosine to Uracil, which is subsequently converted to Thymine during DNA replication.
Stop Codon Induction
Enables the "iSTOP" method, converting CAG, CGA, or CAA codons into UAG, UGA, or UAA stop codons for clean, scarless gene inactivation.
Target Mechanism
Utilizes an evolved adenosine deaminase (e.g., TadA) to convert Adenine to Inosine, which is read as Guanine by DNA polymerase.
Amino Acid Swapping
Ideal for modifying specific protein residues involved in chlorophyll binding or enzyme catalytic sites without disrupting the surrounding genomic structure.
Herbicide Resistance
Introduction of precise point mutations in genes like ALS or psbA to confer resistance to specific inhibitors, serving as powerful selectable markers.
Promoter Tuning
Editing core promoter elements or transcription factor binding sites to subtly increase or decrease the expression of metabolic enzymes.
1. Window Design & Optimization
2. RNP or Plasmid Delivery
3. Clonal Isolation & NGS
4. Functional Characterization
Identification of the target base within the deamination "window" (typically positions 4-8 of the gRNA). Selection of CBE or ABE based on the desired conversion.
Full codon optimization of the base editor fusion protein to match the 64% GC-bias of Chlamydomonas.
Delivery via high-efficiency electroporation. We offer DNA-free RNP delivery for transient editing or stable plasmid integration for sustained activity.
Use of specialized algal buffers to maximize cell viability during transformation.
Analysis of protein function or metabolic output. Confirmation that the single-base change has resulted in the expected physiological shift (e.g., pigment change or enzyme activity).
Delivery of verified, pure monoclonal strains.
No DSB Toxicity
By avoiding double-strand breaks, Base Editing reduces the p53-like stress response and chromosomal rearrangements often seen in edited algae.
High Precision
Allows for specific nucleotide changes that are impossible with standard CRISPR-Cas9, making it the tool of choice for protein engineering.
High Efficiency
Base editing is significantly more efficient than HDR-mediated point mutations in Chlamydomonas, which often suffers from low recombination rates.
Stable Monoclonality
Our rigorous screening ensures that the delivered strains are homozygous (homoplasic) and genetically stable over multiple passages.
1. What is the "editing window" in Base Editing?
The editing window is the specific range of nucleotides within the gRNA target sequence (usually positions 4 to 8) where the deaminase enzyme is active. Proper gRNA design is critical to ensure the target base falls within this range.
2. Can you perform Base Editing in the chloroplast?
Yes. We utilize specialized chloroplast-targeting signals (CTP) fused to the base editor to achieve organelle-specific conversions, which is essential for engineering photosystem components.
3. How do you prevent "bystander" editing?
Bystander editing occurs when multiple C or A bases are present in the editing window. We minimize this by choosing gRNAs that isolate the target base or by using evolved deaminases with narrower windows.
4. Do you use DNA-free RNP delivery for Base Editing?
Yes, we offer RNP delivery of the base editor protein and gRNA. This is the "cleanest" method as it avoids transgene integration and potential silencing issues in Chlamydomonas.
5. What conversion efficiency can be expected?
Depending on the locus and the gRNA, conversion efficiencies typically range from 10% to 50% in the transformed population, which we then isolate into pure monoclonal lines.
6. How is the final strain verified?
We use targeted NGS sequencing as the gold standard to confirm the exact nucleotide change and ensure that no unwanted indels or off-target mutations were created.
7. Is codon optimization necessary for the base editor?
Absolutely. Chlamydomonas has a unique codon bias. We utilize base editors that have been fully optimized to ensure high expression levels in the algal nucleus.
8. What is the typical lead time for a project?
A standard Base Editing project, including design, synthesis, transformation, and NGS verification, typically takes 14 to 18 weeks.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.